342 related articles for article (PubMed ID: 20381638)
1. Host responses to Candida albicans: Th17 cells and mucosal candidiasis.
Conti HR; Gaffen SL
Microbes Infect; 2010 Jul; 12(7):518-27. PubMed ID: 20381638
[TBL] [Abstract][Full Text] [Related]
2. Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections.
Hernández-Santos N; Huppler AR; Peterson AC; Khader SA; McKenna KC; Gaffen SL
Mucosal Immunol; 2013 Sep; 6(5):900-10. PubMed ID: 23250275
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunity and Candida albicans infection.
Moyes DL; Naglik JR
Clin Dev Immunol; 2011; 2011():346307. PubMed ID: 21776285
[TBL] [Abstract][Full Text] [Related]
4. IL-36 and IL-1/IL-17 Drive Immunity to Oral Candidiasis via Parallel Mechanisms.
Verma AH; Zafar H; Ponde NO; Hepworth OW; Sihra D; Aggor FEY; Ainscough JS; Ho J; Richardson JP; Coleman BM; Hube B; Stacey M; McGeachy MJ; Naglik JR; Gaffen SL; Moyes DL
J Immunol; 2018 Jul; 201(2):627-634. PubMed ID: 29891557
[TBL] [Abstract][Full Text] [Related]
5. The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections.
Bishu S; Hernández-Santos N; Simpson-Abelson MR; Huppler AR; Conti HR; Ghilardi N; Mamo AJ; Gaffen SL
Infect Immun; 2014 Mar; 82(3):1173-80. PubMed ID: 24379290
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection.
Gladiator A; Wangler N; Trautwein-Weidner K; LeibundGut-Landmann S
J Immunol; 2013 Jan; 190(2):521-5. PubMed ID: 23255360
[TBL] [Abstract][Full Text] [Related]
7. Candida albicans-epithelial interactions and induction of mucosal innate immunity.
Naglik JR; König A; Hube B; Gaffen SL
Curr Opin Microbiol; 2017 Dec; 40():104-112. PubMed ID: 29156234
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis.
Ferreira MC; Whibley N; Mamo AJ; Siebenlist U; Chan YR; Gaffen SL
Infect Immun; 2014 Mar; 82(3):1030-5. PubMed ID: 24343647
[TBL] [Abstract][Full Text] [Related]
9. Initiation of T-helper cell immunity to Candida albicans by IL-12: the role of neutrophils.
Romani L; Bistoni F; Puccetti P
Chem Immunol; 1997; 68():110-35. PubMed ID: 9329219
[TBL] [Abstract][Full Text] [Related]
10. Adaptive immune responses to Candida albicans infection.
Richardson JP; Moyes DL
Virulence; 2015; 6(4):327-37. PubMed ID: 25607781
[TBL] [Abstract][Full Text] [Related]
11. Th17 cytokines and mucosal immunity.
Dubin PJ; Kolls JK
Immunol Rev; 2008 Dec; 226():160-71. PubMed ID: 19161423
[TBL] [Abstract][Full Text] [Related]
12. Th17 cells in immunity to Candida albicans.
Hernández-Santos N; Gaffen SL
Cell Host Microbe; 2012 May; 11(5):425-35. PubMed ID: 22607796
[TBL] [Abstract][Full Text] [Related]
13. IL-17 signaling in host defense against Candida albicans.
Gaffen SL; Hernández-Santos N; Peterson AC
Immunol Res; 2011 Aug; 50(2-3):181-7. PubMed ID: 21717069
[TBL] [Abstract][Full Text] [Related]
14. IL-22 defines a novel immune pathway of antifungal resistance.
De Luca A; Zelante T; D'Angelo C; Zagarella S; Fallarino F; Spreca A; Iannitti RG; Bonifazi P; Renauld JC; Bistoni F; Puccetti P; Romani L
Mucosal Immunol; 2010 Jul; 3(4):361-73. PubMed ID: 20445503
[TBL] [Abstract][Full Text] [Related]
15. CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis.
Navarathna DH; Stein EV; Lessey-Morillon EC; Nayak D; Martin-Manso G; Roberts DD
PLoS One; 2015; 10(5):e0128220. PubMed ID: 26010544
[TBL] [Abstract][Full Text] [Related]
16. Looking into Candida albicans infection, host response, and antifungal strategies.
Wang Y
Virulence; 2015; 6(4):307-8. PubMed ID: 25590793
[TBL] [Abstract][Full Text] [Related]
17. B Cell Recognition of
Ferreira-Gomes M; Wich M; Böde S; Hube B; Jacobsen ID; Jungnickel B
Front Immunol; 2021; 12():698849. PubMed ID: 34819929
[No Abstract] [Full Text] [Related]
18. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans.
Saijo S; Ikeda S; Yamabe K; Kakuta S; Ishigame H; Akitsu A; Fujikado N; Kusaka T; Kubo S; Chung SH; Komatsu R; Miura N; Adachi Y; Ohno N; Shibuya K; Yamamoto N; Kawakami K; Yamasaki S; Saito T; Akira S; Iwakura Y
Immunity; 2010 May; 32(5):681-91. PubMed ID: 20493731
[TBL] [Abstract][Full Text] [Related]
19. CX3CR1 is dispensable for control of mucosal Candida albicans infections in mice and humans.
Break TJ; Jaeger M; Solis NV; Filler SG; Rodriguez CA; Lim JK; Lee CC; Sobel JD; Netea MG; Lionakis MS
Infect Immun; 2015 Mar; 83(3):958-65. PubMed ID: 25547797
[TBL] [Abstract][Full Text] [Related]
20. Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm.
Liu JZ; Pezeshki M; Raffatellu M
Cytokine; 2009; 48(1-2):156-60. PubMed ID: 19665391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
